BMS-2

CAS No. 888719-03-7

BMS-2( —— )

Catalog No. M21662 CAS No. 888719-03-7

BMS-2 is a Met/Flt-3/VEGFR2 tyrosine kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 86 Get Quote
5MG 143 Get Quote
10MG 230 Get Quote
25MG 430 Get Quote
50MG 621 Get Quote
100MG 897 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-2
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-2 is a Met/Flt-3/VEGFR2 tyrosine kinase inhibitor.
  • Description
    BMS-2 is a Met/Flt-3/VEGFR2 tyrosine kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    Animal Model:MiceDosage:5, 10 mg/kg Administration:IV, POResult:Showed extensive extravascular distribution and a favorable half-life.Animal Model:Nude mice Dosage:6.25, 12.5, 25 and 50 mg/kg Administration:PO, once a day Result:Showed antitumor activity in dose-dependet.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    Met|FLT3|VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    888719-03-7
  • Formula Weight
    458.42
  • Molecular Formula
    C25H16F2N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (218.14 mM)
  • SMILES
    Fc1ccc(cc1)-n1cccc(C(=O)Nc2ccc(Oc3ccnc4[nH]ccc34)c(F)c2)c1=O
  • Chemical Name
    1-(4-Fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[23-b]pyridin-4-yloxy)phenyl]-2-oxopyridine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SRI 31215

    SRI 31215 a small molecule that acts as a triplex inhibitor of matriptase hepsin and HGFA and mimics the activity of HAI-1/2 endogenous inhibitors of HGF activation with IC50s of 0.69 μM 0.65 μM 0.3 μM.

  • Tyrosine kinase inhi...

    Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.

  • Savolitinib

    Savolitinib (AZD-6094) is a potent, highly selective, and orally bioavailable c-Met inhibitor with IC50s of 5 nM and 3 nM for c-Met and p-Met.